|
| |
Image Results
Loading...
Loading...
UCB PHARMA 1420 Pages on BioPortfolio:
BioPortfolio - UCB Pharma
CNS Research, UCB Pharma SA, Chemin du Foriest, B-1420 Braine-l'Alleud,, Eur J Pharmacol. 2009 Jul 1;614(1-3):30-7. Epub 2009 Apr 19. ...
http://www.bioportfolio.com/biocorporate/10415-UCB+Pharma.ht...
|
BioPortfolio - UCB Pharma - Profile
B-1420. Belgium. Tel: 00 32 2 386 2111. Fax: 00 32 2 386 2704. Email: Recent Publications by UCB Pharma: • A pharmacodynamic Markov mixed-effects model for
...
http://www.bioportfolio.com/biocorporate/10415-UCB%2BPharma....
|
BioPortfolio - UCB Pharma - Profile
Like any other drugs, antiallergic medications can be associated with...16th July, 2009. UCB Pharma SA, Chemin du Foriest, Braine I' Alleud, B-1420 Belgium.
...
http://www.bioportfolio.com/biocorporate/10415-UCB%252525252...
|
|
BioPortfolio - UCB S.A - Profile
UCB S.A., In vitro Pharmacology, Building R4, Chemin du Foriest, 1420- ... UCB S. A., Pharma Sector, Department of Global Product Safety and- Xenobiotica. ...
http://www.bioportfolio.com/biocorporate/31345-UCB%252BS.A.p...
|
BioPortfolio - UCB S.A.
BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug ... UCB S.A., R&D, Chemin du Foriest, B-1420 Braine-l'Alleud, Belgium. ...
http://www.bioportfolio.com/biocorporate/10406-UCB_S.A..html...
| Results from other life science and pharmaceutical sites:
UCB Pharma research day—25 October 2007 'Glia-neuron interactions ...
2CNS Pharmacology, Preclinical CNS Research, UCB Pharma, Chemin du Foriest, Building R9, Room 1.1.15, 1420 Braine-l'Alleud, Belgium ...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2246004/...
|
British Journal of Pharmacology - Abstract of article: Anti ...
Correspondence: Dr A Matagne, CNS Research, UCB Pharma SA, Chemin du Foriest, B- 1420 Braine-l'Alleud, Belgium. E-mail: Alain.Matagne@UCB-Group.com ...
http://www.nature.com/bjp/journal/v154/n8/abs/bjp2008198a.ht...
|
Profile of the new pyrrolidone derivative seletracetam (ucb 44212 ...
CNS Research, UCB Pharma SA, Chemin du Foriest, B-1420 Braine-l'Alleud, Belgium. Alain.Matagne@UCB.com. Seletracetam is a pyrrolidone derivative with a ...
http://www.ncbi.nlm.nih.gov/pubmed/19383493...
|
The pharmacokinetics, CNS pharmacodynamics and adverse event ...
Correspondence Dr Maria Laura Sargentini-Maier, UCB Pharma S.A., Global Exploratory Development, Chemin du Foriest, Braine-l'Alleud B-1420, Belgium. ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=24...
|
Discriminant validity, responsiveness and reliability of the ...
2Global Health Outcomes Research, UCB Pharma, Chemin du Foriest, 1420 Braine-l' Alleud, Belgium. 3Global Health Outcomes Research, UCB Pharma, 208 Bath Road ...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2714119/...
|
Clinical Pharmacology & Therapeutics - Abstract of article ...
Correspondence: Réginald Hulhoven, MD, PhD, UCB s.a. Pharma Sector, Chemin du Foriest, B 1420 Braine-l'Alleud, Belgium. †Deceased. ...
http://www.nature.com/clpt/journal/v61/n3/abs/clpt199722a.ht...
|
Determination of phospholipidosis potential based on gene ...
UCB Pharma SA, Non-Clinical Development, Chemin du Foriest, 1420 Braine-l'Alleud , Belgium. franck.atienzar@ucb-group.com ...
http://www.ncbi.nlm.nih.gov/pubmed/17175557...
|
ar2702 ARJ Research article Discriminant validity, responsiveness ...
Competing interests This paper was funded by UCB Pharma, which sponsored the clinical trial in which the data were collected. JTO is a paid consultant of ...
http://www.biomedcentral.com/content/download/xml/ar2702.xml...
|
A novel needle for subcutaneous injection of interferon beta-1a ...
10 Oct 2008 ... 3BD Medical – Pharmaceutical Systems, Le Pont de Claix, France. 4UCB Pharma SA, Chemin du Foriest, 1420 Braine l'Alleud, Belgium ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=25...
|
1471-2377-8-38 1471-2377 Technical advance A novel needle for ...
Competing interests AJ is a current employee of UCB Pharma SA, Braine l'Alleud, Belgium, and GBB was a previous employee of Merck Serono International S.A. ...
http://www.biomedcentral.com/content/download/xml/1471-2377-...
|
|
